At a glance
ClinicalIndex Comparison RecordN/ACompleted· 79 enrolled
Drug / intervention
T380A Intrauterine Copper Contraceptivedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
(TRIBE) Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users
In Brief
A clinical study evaluating T380A Intrauterine Copper Contraceptive for Intrauterine Devices, Copper and 3 related conditions. Completed, enrolled 79 participants across 1 site.
Detailed Summary
This study aims to use validated tools as well as new technology to examine changes in bleeding patterns among women who are initiating the copper T380A IUD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedDec 2014
Primary CompletionAug 2016
Study CompletionFeb 2017
TodayJul 2026
First PostedDec 8, 2014
Enrollment StartDec 1, 2014
Primary CompletionAug 1, 2016
Study CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.6 years ago
Interventions
T380A Intrauterine Copper Contraceptivedevice
The T380A is intrauterine device (IUD) that used to prevent pregnancy. It is a soft, flexible T-shaped device made primarily of plastic and copper that is inserted into the uterus.